Laparoscopic versus open gastrectomy for locally advanced gastric cancer after neoadjuvant chemotherapy: a comprehensive contrastive analysis with propensity score matching

Background Laparoscopic gastrectomy (LG) is increasingly applied in locally advanced gastric cancer (LAGC) after neoadjuvant chemotherapy (NC). However, there is no study to comprehensively evaluate the clinicopathological, prognostic, and laboratory data such as nutrition, immune, inflammation-associated indexes, and tumor markers between LG and open gastrectomy (OG) for LAGC following NC. Methods The clinicopathological, prognostic, and laboratory data of LAGC patients with clinical stage of cT2-4aN1-3M0 who underwent gastrectomy after NC were retrospectively collected. The effects of LG and OG were compared after propensity score matching (PSM). Results This study enrolled 148 cases, of which 110 cases were included after PSM. The LG group had a shorter length of incision ( P < 0.001) and was superior to OG group in terms of blood loss ( P < 0.001), postoperative first flatus time ( P < 0.001), and postoperative first liquid diet time ( P = 0.004). No significant difference was found in postoperative complications ( P = 0.482). Laboratory results showed that LG group had less reduced red blood cells ( P = 0.039), hemoglobin ( P = 0.018), prealbumin ( P = 0.010) in 3 days after surgery, and less reduced albumin in 1 day ( P = 0.029), 3 days ( P = 0.015), and 7 days ( P = 0.035) after surgery than the OG group. The systemic immune-inflammation index and systemic inflammatory response index were not significantly different between the two groups. As for oncological outcomes, there were no significant differences in postoperative tumor markers of CEA ( P = 0.791), CA199 ( P = 0.499), and CA724 ( P = 0.378). The 5-year relapse-free survival rates ( P = 0.446) were 46.9% and 43.3% in the LG and OG groups, with the 5-year overall survival rates ( P = 0.742) being 46.7% and 52.1%, respectively; the differences were not statistically significant. Multivariate Cox regression analysis revealed that tumor size ≥ 4 cm ( P = 0.021) and the absence of postoperative adjuvant chemotherapy ( P = 0.012) were independent risk factors for overall survival. Conclusions LG has faster gastrointestinal recovery, better postoperative nutritional status, and comparable oncological outcomes than OG, which can serve as an alternative surgical method for LAGC patients after NC.